124 related articles for article (PubMed ID: 1319957)
1. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.
Price PM; Banerjee R; Jeffrey AM; Acs G
Hepatology; 1992 Jul; 16(1):8-12. PubMed ID: 1319957
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine.
Price PM; Banerjee R; Acs G
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8541-4. PubMed ID: 2813411
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
Parker WB; Shaddix SC; Allan PW; Arnett G; Rose LM; Shannon WM; Shealy YF; Montgomery JA; Secrist JA; Bennett LL
Mol Pharmacol; 1992 Feb; 41(2):245-51. PubMed ID: 1311407
[TBL] [Abstract][Full Text] [Related]
4. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
Fourel I; Saputelli J; Schaffer P; Mason WS
J Virol; 1994 Feb; 68(2):1059-65. PubMed ID: 8289335
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
Shaw T; Mok SS; Locarnini SA
Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
Seifer M; Hamatake RK; Colonno RJ; Standring DN
Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors.
Zhang P; Liu F; Guo F; Zhao Q; Chang J; Guo JT
Antiviral Res; 2016 Jul; 131():40-8. PubMed ID: 27083116
[TBL] [Abstract][Full Text] [Related]
8. Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virions.
Nagahata T; Kitagawa M; Matsubara K
Antimicrob Agents Chemother; 1994 Apr; 38(4):707-12. PubMed ID: 7518217
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
[TBL] [Abstract][Full Text] [Related]
10. Quantitative polymerase chain reaction for hepatitis B virus DNA.
Wu J; Sullivan DE; Gerber MA
J Virol Methods; 1994 Oct; 49(3):331-41. PubMed ID: 7868650
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine.
Tisdale M; Ellis M; Klumpp K; Court S; Ford M
Antimicrob Agents Chemother; 1995 Nov; 39(11):2454-8. PubMed ID: 8585725
[TBL] [Abstract][Full Text] [Related]
13. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.
Matthes E; Funk A; Krahn I; Gaertner K; von Janta-Lipinski M; Lin L; Will H; Sirma H
Antimicrob Agents Chemother; 2007 Jul; 51(7):2523-30. PubMed ID: 17404006
[TBL] [Abstract][Full Text] [Related]
14. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.
Innaimo SF; Seifer M; Bisacchi GS; Standring DN; Zahler R; Colonno RJ
Antimicrob Agents Chemother; 1997 Jul; 41(7):1444-8. PubMed ID: 9210663
[TBL] [Abstract][Full Text] [Related]
15. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil.
Balakrishna Pai S; Liu SH; Zhu YL; Chu CK; Cheng YC
Antimicrob Agents Chemother; 1996 Feb; 40(2):380-6. PubMed ID: 8834884
[TBL] [Abstract][Full Text] [Related]
18. Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication.
Lee CD; Ott M; Thyagarajan SP; Shafritz DA; Burk RD; Gupta S
Eur J Clin Invest; 1996 Dec; 26(12):1069-76. PubMed ID: 9013081
[TBL] [Abstract][Full Text] [Related]
19. [Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus].
Wu JM; Lin JS; Xie N; Jiang FC; Liang KH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):268-70. PubMed ID: 12773236
[TBL] [Abstract][Full Text] [Related]
20. Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein.
Chi WJ; Doong SL; Lin-Shiau SY; Boone CW; Kelloff GJ; Lin JK
Carcinogenesis; 1998 Dec; 19(12):2133-8. PubMed ID: 9886568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
